Healthcare has made tremendous strides in producing disclosures, but it is still struggling to produce understanding. A hospital posts a price file, a health plan publishes negotiated rates, and a provider gives an estimate. But the patient may still not comprehend what they are being asked to approve or what the likely cost pathway looks like.
The quiet failure of healthcare transparency is that we have spent years trying to make prices more visible, but visibility is not the same as usability. A price that exists somewhere is not the same as a patient understanding the financial commitment they are making before care begins. Price transparency matters, but it is just not enough.
The next frontier is not whether healthcare can disclose more numbers, but whether healthcare can explain what those numbers actually mean. Most consumer markets understand the difference between a price and a purchase. A flight price means one thing if it includes luggage and another if it does not.
Healthcare often asks patients to make decisions with less clarity than they would expect in simpler markets. The deeper problem is not only that prices are hidden, but that the object being priced is unclear. A patient does not experience healthcare as a billing code or a machine-readable file.
CMS hospital price transparency rules and Transparency in Coverage rules are major steps, but they do not automatically solve the patient's real question: "What will this episode of care likely cost me, and what exactly is included?" A machine-readable file may be useful to researchers, employers, regulators, or third-party tools, but it is not necessarily useful to a patient deciding whether to proceed with surgery next month.
Estimates can become compliance theater. The No Surprises Act made good faith estimates part of the conversation for uninsured or self-pay patients, but an estimate can still fail if it behaves more like a legal artifact than a communication tool. There is a difference between saying, "Here is our best estimate based on the information we have," and saying, "Here is what this pathway includes, what it does not include, where uncertainty lives, and when you will be asked to make another decision."
Healthcare tends to be more comfortable with the first version, which discloses but does not explain. Medicine is genuinely uncertain, and a surgeon may not know exactly what will be required until the procedure begins. But uncertainty should not be used as a shield against explaining the foreseeable.
Predictable points where costs often change, common exclusions, typical add-ons, and follow-up needs should be clearly communicated to patients. Patients do not need false certainty; they need honest uncertainty. "Available" is not the same as "understood," and patients are not confused because they are lazy.
Healthcare information is often fragmented by design, with the hospital knowing one part and the physician group knowing another. A maternity patient may know the hospital's posted charge but not understand how anesthesia, neonatal care, complications, or out-of-network professionals could change the final bill.
Estimates can be misleading, and what looks cheaper may only be less bundled, less explicit, or less honest about what is likely to happen next. Cost confusion changes care, and patients are more likely to move forward when they understand what they are committing to.
The next phase of transparency should focus less on publishing more disconnected numbers and more on making the treatment quote understandable. A usable quote should explain the care pathway, distinguish between included services, excluded services, likely add-ons, conditional costs, and true unknowns, and make clear when a patient will be asked for new consent if the plan changes.
A transparency standard should reward completeness, not punish it. Good providers who explain costs carefully can look more expensive than competitors who advertise incomplete prices. The honest quote loses to the attractive fragment, which is a perverse incentive.
Healthcare transparency should not end at disclosure; it should end at comprehension. Until then, the system will keep congratulating itself for publishing prices while patients continue asking the only question that really matters: "What am I actually agreeing to?"
